Saturday, August 27, 2016

Today’s articles on Sectors

Get Over Your Trauma: Dial Up Strong Dividend Growth With This Telco
By George Schneider • 27 comments
First Solar: An Undervalued Titan In The Solar Industry Poised To Outperform
By Endeavor Analytics • 55 comments
Bank Of America Is Breaking Out
By Josh Arnold • 84 comments
Editors' Picks
Amazon's Retail Store; Google, Facebook To Pay For News?; Rackspace Buyout - Eye On Tech
By Bret Kenwell
Workday: And Some Say 42% Growth Is Not Enough
By Bert Hochfeld
Harvest 12.5% Yields In Alliance One International's 5-Year Bonds Maturing July 2021
By Randy Durig
The Advisory Board: Cheapest Valuation In 4 Years? Not So Fast
By Michael Boyd
Polaris Infrastructure: There's Still More To Go
By Peter Kaye
More Editors' Picks»

Basic Materials
Exxon Mobil: Don't Rule Out A Recovery by Fundamental Investing
Seadrill: Can It Get Any Worse? by Sarfaraz A. Khan
Gold Juniors' Q2'16 Fundamentals by Adam Hamilton
Cliffs Natural Resources: Good Long-Term Buy by Orthodox Investor
Global LNG Situation Will Play Out In Shell's Favor by Zoltan Ban
More Basic Materials»
Consumer Goods
Tesla Batteries: Well-Built, Poorly Designed by Max Greve
Dividend Investors Look Out, There's No One To Catch You At Coca-Cola by Reuben Gregg Brewer
General Motors Will Completely Transform Their Business Model by Joseph Bonaccorso
Tesla's Larger Battery Packs Are A Feature, Not A Waste by Aurelien Windenberger
On The Ground: August IRA Activity by William Colsher
More Consumer Goods»

Financial
Goldman Sachs' And Wells Fargo's Derivatives Books by Kurt Dew
HSBC: Up To 21% Of Market Cap Could Be Returned To Shareholders Over The Next 12 Months by Renaissance Research
Aflac: A Great Example Of Why You Should Be 'Rooting' For Lower Prices by Eli Inkrot
Toronto-Dominion Eases Concerns, Beats Estimates by Mat Litalien
Double Your Money With This Newly Issued Baby Bond (Well, In 10 Years) by Arbitrage Trader
More Financial»
Healthcare
Updating My Price Target On Pfizer by Alexander J. Poulos
Biotech Forum Daily Digest: Clinton Takes A Swipe At Biotech, Revisiting The Bullish Case On Cempra by Bret Jensen
A Merck Versus Bristol Showdown by EP Vantage
Can Pernix Turn Things Around? by ONeil Trader
Meager Growth For Valeant And No Improvement Of Profitability In The Next Two Years, According To Its Management And Their Budget by Endorama Global
More Healthcare»
Industrial Goods
Elon Musk Saves SolarCity by Chris DeMuth Jr.
The Future Of Boeing's Defense Segment by Atta Khan
3M Company: A Market Correction Conviction Buy by David J. Waldron
Joy Global: Merger Arbitrage Play by The Ivy League
Why Snap-On Is Worth A Spot On Your Watchlist by Intelligent Trend Follower
More Industrial Goods»
Services
The Geo Group: An 11% Yield Income Play by Achilles Research
Starbucks' DGR Is All Fired Up by Mat Litalien
Ulta: Will Its Bubble Burst? by Josh Arnold
Was The Sell-Off Justified? by Jonathan Weber
Crazy Spike Of The Day: Eagle Bulk Shipping by J Mintzmyer
More Services»
Technology
Cisco's Shares Are Dirt Cheap But Here's How To Get Them At An Even Larger, 22.7% Discount by Dividend Sensei
Facebook Can't Stop, Won't Stop by Valuentum
SunPower: More Than Just Numbers by Keith Williams
Nokia Looks To Brighter Future Amid Challenging Present by Valuentum
Amazon's New Growth Driver by Quinn Foley
More Technology»
Utilities
Can Calpine Ever Win? by Paulo Santos
More Utilities»

Please do not forward this email. It allows direct access to your Seeking Alpha Portfolio.

Why are you receiving this? You subscribed to Sectors at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017

No comments:

Post a Comment

Gimme your 2 cents!

Banner Ad